H.C. Wainwright analyst Matthew Caufield reiterated a Buy rating on FibroBiologics, Inc. (FBLG – Research Report) today and set a price ...

An estimated 23 percent of adults worldwide suffer from chronic low back pain, and as many as 84 percent of us will ...

Obeticholic acid, which is marketed as Ocaliva as a treatment for a type of liver disease known as primary biliary cholangitis, has come under scrutiny recently. Although the US Food and Drug ...

With early detection and personalised therapies, Artificial Intelligence (AI) can make a significant mark for the treatment of heart diseases in India, said experts on Sunday. Heart disease is a ...

Lady Gaga debuted her new single “Disease” — an electro-pop song about curing a lover’s “tortured” disease — on Thursday night. The upbeat track was written by Michael Polansky ...

Monopar Therapeutics has secured an exclusive global license from Alexion Pharmaceuticals to develop and commercialize ALXN-1840, a promising treatment for Wilson disease, following a successful ...

Agomab’s lead candidate is being investigated as a treatment for patients with fibrostenosing Crohn’s disease (FSCD). Credit: Hananeko_Studio via Shutterstock. Agomab Therapeutics has secured $89m in ...

type TTR, addressing the underlying cause of the disease. It is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults. HELIOS-B was a ...

The transcriptomes revealed disease-specific cellular differences and mapped potential treatment responses for Crohn's and colitis. The first author of the paper, Dr. Tom Thomas of the Kennedy ...

Similarly, using muscles you do not use often can result in fatigue and pain. Finally, specific health conditions, such as degenerative disc disease, can cause lower back pain. Your spine is made up ...

Motor neurone disease, which affects over 5,000 people in the UK at any given time, is characterised by progressive muscle atrophy. While current treatments only address symptoms, Ellorarxine ...

Clinicians are hopeful the new approach will give people with aggressive cervical cancer additional options for treatment, particularly those who face barriers to healthcare. Cervical cancer ...